+
CCI Approves Strategic Healthcare Sector Combination Involving TPG and GIC
ECONOMY & POLICY

CCI Approves Strategic Healthcare Sector Combination Involving TPG and GIC

The Competition Commission of India (CCI) has approved a proposed combination involving multiple entities, including Waverly Pte. Ltd., TPG Growth V SF Markets Pte. Ltd., TPG Growth III SF Pte. Ltd., Asia Healthcare Holdings Pte. Ltd. (AHH Singapore), Rhea Healthcare Private Limited, Asia Healthcare Advisory Holdings LLP (AHH LLP), and Asian Institute of Nephrology and Urology Private Limited (AINU).

Key aspects of the proposed combination include:

Waverly’s planned subscription to Ordinary Shares and Class F Redeemable Preference Shares in AHH Singapore.

Specific rights for Growth V in AHH Singapore, Rhea, and AHH LLP.

Certain rights for Growth III related to AHH Singapore, specifically concerning AINU and its downstream entities.

Rhea’s acquisition of full ownership of AHH Singapore’s shareholding in AINU (the “AINU Transfer”).

Proposed equity share issuance by Rhea to AHH Singapore as consideration for the AINU Transfer.

Growth III and Growth V are investment funds managed by TPG Inc., a global investment firm. The TPG Group, including its subsidiaries and affiliates, operates primarily in sectors like technology, healthcare, consumer goods, and financial services.

Waverly is a wholly owned subsidiary of Lathe Investment Pte. Ltd., which is in turn wholly owned by GIC (Ventures) Pte. Ltd. Waverly is part of a group of investment holding companies managed by GIC Special Investments Private Limited.

AHH is a Singapore-based company focused on long-term investments in healthcare services across India, particularly in maternal, child, urology, nephrology, and related fields. It is jointly owned by the TPG and GIC groups.

Rhea operates a hospital chain specialising in women’s healthcare and fertility services and is set to merge with Nova Medical Centres Private Limited. Rhea operates in 19 states and 3 union territories in India.

AINU, located in South India, specialises in urology, nephrology, dialysis, and kidney transplants, with a network of seven hospitals across various cities.

AHH LLP provides advisory services to AHH Singapore and its downstream entities in strategy, finance, and operational matters, excluding investment management.

A detailed order from the Commission will follow.

The Competition Commission of India (CCI) has approved a proposed combination involving multiple entities, including Waverly Pte. Ltd., TPG Growth V SF Markets Pte. Ltd., TPG Growth III SF Pte. Ltd., Asia Healthcare Holdings Pte. Ltd. (AHH Singapore), Rhea Healthcare Private Limited, Asia Healthcare Advisory Holdings LLP (AHH LLP), and Asian Institute of Nephrology and Urology Private Limited (AINU). Key aspects of the proposed combination include: Waverly’s planned subscription to Ordinary Shares and Class F Redeemable Preference Shares in AHH Singapore. Specific rights for Growth V in AHH Singapore, Rhea, and AHH LLP. Certain rights for Growth III related to AHH Singapore, specifically concerning AINU and its downstream entities. Rhea’s acquisition of full ownership of AHH Singapore’s shareholding in AINU (the “AINU Transfer”). Proposed equity share issuance by Rhea to AHH Singapore as consideration for the AINU Transfer. Growth III and Growth V are investment funds managed by TPG Inc., a global investment firm. The TPG Group, including its subsidiaries and affiliates, operates primarily in sectors like technology, healthcare, consumer goods, and financial services. Waverly is a wholly owned subsidiary of Lathe Investment Pte. Ltd., which is in turn wholly owned by GIC (Ventures) Pte. Ltd. Waverly is part of a group of investment holding companies managed by GIC Special Investments Private Limited. AHH is a Singapore-based company focused on long-term investments in healthcare services across India, particularly in maternal, child, urology, nephrology, and related fields. It is jointly owned by the TPG and GIC groups. Rhea operates a hospital chain specialising in women’s healthcare and fertility services and is set to merge with Nova Medical Centres Private Limited. Rhea operates in 19 states and 3 union territories in India. AINU, located in South India, specialises in urology, nephrology, dialysis, and kidney transplants, with a network of seven hospitals across various cities. AHH LLP provides advisory services to AHH Singapore and its downstream entities in strategy, finance, and operational matters, excluding investment management. A detailed order from the Commission will follow.

Next Story
Infrastructure Transport

Syama Prasad Mookerjee Port Partners to Redevelop Nimtala Ghat

Kolkata: Syama Prasad Mookerjee Port, Kolkata (SMPK), signed a Memorandum of Understanding (MoU) on Tuesday with PS Group Realty Private Limited to redevelop and beautify Nimtala Ghat as part of PS Group’s Corporate Social Responsibility (CSR) initiative.The agreement was formalised at SMPK’s Head Office at 15, Strand Road, in the presence of SMPK chairman Rathendra Raman, deputy chairman Samrat Rahi, PS Group directors Saurav Dugar, Gaurav Dugar, Arun Sancheti, and senior SMPK officials.Under the MoU, PS Group will undertake the full redevelopment and permitted construction of Nimtala Imm..

Next Story
Infrastructure Urban

CSIR-NCL and Covestro Collaborate to Upcycle Polyurethane Waste

In a move towards sustainable plastic waste management, Pune-based CSIR-National Chemical Laboratory (CSIR-NCL) signed a Memorandum of Understanding (MoU) with Covestro (India) Private Limited on Wednesday to develop innovative upcycling technologies for polyurethane waste.Polyurethane is notoriously difficult to recycle, with current methods often proving inefficient, costly, and environmentally harmful. This collaboration aims to address existing challenges, including high energy usage and deterioration of material quality during recycling.Ashish Lele, director of CSIR-NCL, stated, “This p..

Next Story
Infrastructure Urban

Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?